These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15863260)

  • 21. Nothing is perfect, not even the local lymph node assay: a commentary and the implications for REACH.
    Basketter DA; McFadden JF; Gerberick F; Cockshott A; Kimber I
    Contact Dermatitis; 2009 Feb; 60(2):65-9. PubMed ID: 19207375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of non-radio isotopic endpoint of murine local lymph node assay based on 5-bromo-2'-deoxyuridine (BrdU) incorporation.
    Takeyoshi M; Yamasaki K; Yakabe Y; Takatsuki M; Kimber I
    Toxicol Lett; 2001 Mar; 119(3):203-8. PubMed ID: 11246173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contact allergenic potency: correlation of human and local lymph node assay data.
    Gerberick GF; Robinson MK; Ryan CA; Dearman RJ; Kimber I; Basketter DA; Wright Z; Marks JG
    Am J Contact Dermat; 2001 Sep; 12(3):156-61. PubMed ID: 11526521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals.
    Gerberick GF; Ryan CA; Dearman RJ; Kimber I
    Methods; 2007 Jan; 41(1):54-60. PubMed ID: 16938465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skin sensitization potency of isoeugenol and its dimers evaluated by a non-radioisotopic modification of the local lymph node assay and guinea pig maximization test.
    Takeyoshi M; Iida K; Suzuki K; Yamazaki S
    J Appl Toxicol; 2008 May; 28(4):530-4. PubMed ID: 17929237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization and evaluation of a modified local lymph node assay using ATP content as a non-radio isotopic endpoint.
    Idehara K; Yamagishi G; Yamashita K; Ito M
    J Pharmacol Toxicol Methods; 2008; 58(1):1-10. PubMed ID: 18462956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skin sensitization potency of methyl methacrylate in the local lymph node assay: comparisons with guinea-pig data and human experience.
    Betts CJ; Dearman RJ; Heylings JR; Kimber I; Basketter DA
    Contact Dermatitis; 2006 Sep; 55(3):140-7. PubMed ID: 16918612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and utilization of an ex vivo bromodeoxyuridine local lymph node assay protocol for assessing potential chemical sensitizers.
    Williams WC; Copeland C; Boykin E; Quell SJ; Lehmann DM
    J Appl Toxicol; 2015 Jan; 35(1):29-40. PubMed ID: 24532485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B cell increases and ex vivo IL-2 production as secondary endpoints for the detection of sensitizers in non-radioisotopic local lymph node assay using flow cytometry.
    Jung KM; Jang WH; Lee YK; Yum YN; Sohn S; Kim BH; Chung JH; Park YH; Lim KM
    Toxicol Lett; 2012 Mar; 209(3):255-63. PubMed ID: 22245253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Further development of LLNA:DAE method as stand-alone skin-sensitization testing method and applied for evaluation of relative skin-sensitizing potency between chemicals.
    Yamashita K; Shinoda S; Hagiwara S; Itagaki H
    J Toxicol Sci; 2015 Apr; 40(2):137-50. PubMed ID: 25786520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of skin sensitization potential of chemicals by local lymph node assay using 5-bromo-2-deoxyuridine with flow cytometry.
    Han BI; Yi JS; Seo SJ; Kim TS; Ahn I; Ko K; Kim JH; Bae S; Lee JK
    Regul Toxicol Pharmacol; 2019 Oct; 107():104401. PubMed ID: 31158384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A quantitative approach to assess the potency of skin sensitizers in the elicitation phase.
    Ezendam J; Vermeulen JP; de Klerk A; de Jong WH; van Loveren H
    Toxicology; 2012 Sep; 299(1):20-4. PubMed ID: 22564262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between experimental human and murine skin sensitization induction thresholds.
    Api AM; Basketter D; Lalko J
    Cutan Ocul Toxicol; 2015; 34(4):298-302. PubMed ID: 25430073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An assessment of the skin sensitisation hazard of a group of polyfunctional silicones using a weight of evidence approach.
    Petry T; Bosch A; Coste X; Dupuis V; Eigler D; Germain P
    Regul Toxicol Pharmacol; 2012 Nov; 64(2):305-14. PubMed ID: 22981813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulphanilic acid: divergent results in the guinea pig maximization test and the local lymph node assay.
    Basketter DA; Scholes EW; Cumberbatch M; Evans CD; Kimber I
    Contact Dermatitis; 1992 Oct; 27(4):209-13. PubMed ID: 1451484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A nonradioisotopic endpoint for measurement of lymph node cell proliferation in a murine allergic contact dermatitis model, using bromodeoxyuridine immunohistochemistry.
    Lee JK; Park JH; Park SH; Kim HS; Oh HY
    J Pharmacol Toxicol Methods; 2002; 48(1):53-61. PubMed ID: 12750042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Iida K; Shiraishi K; Hoshuyama S
    J Appl Toxicol; 2005; 25(2):129-34. PubMed ID: 15744759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Local lymph node assay: validation assessment for regulatory purposes.
    Gerberick GF; Ryan CA; Kimber I; Dearman RJ; Lea LJ; Basketter DA
    Am J Contact Dermat; 2000 Mar; 11(1):3-18. PubMed ID: 10684384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of an ex vivo murine local lymph node assay: multiple endpoint comparison.
    Piccotti JR; Knight SA; Gillhouse K; Lagattuta MS; Bleavins MR
    J Appl Toxicol; 2006; 26(4):333-40. PubMed ID: 16705757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The local lymph node assay: results of a final inter-laboratory validation under field conditions.
    Scholes EW; Basketter DA; Sarll AE; Kimber I; Evans CD; Miller K; Robbins MC; Harrison PT; Waite SJ
    J Appl Toxicol; 1992 Jun; 12(3):217-22. PubMed ID: 1629518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.